Screener
Altimmune ALT Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Altimmune’s reported figures.
Based on the most recent quarter.
The source filing: Altimmune’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326190-26-000040
FAQ
- What is Altimmune's debt-to-equity?
- Altimmune (ALT) reported debt-to-equity of 0.1× in Q1 2026.
- How has Altimmune's debt-to-equity changed year-over-year?
- Altimmune's debt-to-equity increased by 7100.0% year-over-year, from 0× to 0.1×.
- What is the long-term trend for Altimmune's debt-to-equity?
- Over 5 years (2020 to 2025), Altimmune's debt-to-equity has grown at a 57.8% compound annual growth rate (CAGR), from 0× to 0.2×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Altimmune's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude